“The existing scenario has exposed some structural weaknesses during the EU’s medicines provide chain along with a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She proposed that provide chain troubles be tackled in an EU pharmaceutical tactic envisioned for being released by